Even though ZEB1 was successfully and stably knocked-out in HS578T-Hyg breast cancer cells and M13HS tumor hybrids, the phenotype of the ZEB1-KO cells was only moderately altered as compared to their wildtype counterparts. Here, ZEB1 is linked to breast cancer.